Blackberry and Blueberry Anthocyanin Supplementation Counteract High-Fat-Diet-Induced Obesity by Alleviating Oxidative Stress and Inflammation and Accelerating Energy Expenditure

Wu, Tao; Gao, Yufang; Guo, Xueqi; Zhang, Min; Gong, Lingxiao

doi:https://doi.org/10.1155/2018/4051232

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2018 | Article ID 4051232 | https://doi.org/10.1155/2018/4051232

Blackberry and Blueberry Anthocyanin Supplementation Counteract High-Fat-Diet-Induced Obesity by Alleviating Oxidative Stress and Inflammation and Accelerating Energy Expenditure

Tao Wu,^1,2,3Yufang Gao,¹Xueqi Guo,¹Min Zhang,^1,2and Lingxiao Gong³

Academic Editor: Silvana Hrelia

Received22 Feb 2018

Revised14 May 2018

Accepted03 Jun 2018

Published02 Jul 2018

Abstract

Many studies indicate that an anthocyanin-rich diet has beneficial effects preventing metabolic disease. In the present study, the molecular mechanism underlying the antiobesity effect of consuming blackberry anthocyanins (BLA) and blueberry anthocyanins (BBA) was investigated in high-fat-diet- (HFD-) fed C57BL/6 mice. Sixty mice were administered a low-fat diet (LFD), a HFD, or a HFD plus orlistat, and BLA or BBA in their daily food for 12 weeks. As a result, the consumption of BLA and BBA inhibited body weight gain by 40.5% and 55.4%, respectively, in HFD-fed mice. The BLA and BBA treatments markedly reduced serum and hepatic lipid levels and significantly increased hepatic superoxide dismutase and glutathione peroxidase activities. In addition, the treatments effectively increased fecal acetate and butyrate levels and significantly attenuated expression of tumor necrosis factor TNF-α, interleukin-6, and nuclear factor-kappaB genes. Moreover, gas chromatography time-of-flight mass spectroscopy results suggested that BLA and BBA significantly affected the hepatic lipid and glucose metabolic pathways, including glycerophospholipid metabolism, glutathione metabolism, and the insulin-signaling pathway. Therefore, BLA and BBA ameliorated diet-induced obesity by alleviating oxidative stress and inflammation and accelerating energy expenditure.

1. Introduction

Obesity has been officially recognized as a chronic disease and continues to be a major global health challenge. Obesity results from an extreme imbalance between energy expenditure and energy consumption [1, 2]. Phentermine, orlistat, liraglutide, lorcaserin, phentermine/topiramate extended release, and naltrexone sustained release (SR)/bupropion SR have been approved as antiobesity medications [3, 4]. However, these drugs cause unwanted side effects [3, 5]. Therefore, food components to counteract obesity are needed.

Anthocyanins are water-soluble polyphenolic compounds commonly found in the daily diet, particularly in pigmented fruits and vegetables [6, 7]. These substances have attracted attention recently for their potential pharmacological activities, including anti-inflammatory, antioxidative, and antiobesity effects [8, 9]. Several studies have demonstrated that anthocyanin-rich blueberry [10, 11], mulberry [12, 13], wolfberry [14], cherry [15, 16], red cabbage microgreen [17], black rice [18, 19], purple corn [20], and sweet potato [21, 22] have beneficial effects on body weight management in various models. However, the specific molecular mechanisms whereby anthocyanins alter bodyweight gain are not fully understood. Possible mechanisms include attenuation of high-sensitivity C-reactive protein, reduced expression of sodium-dependent glucose transporter 1, lowered food availability, and normalization of the ratio between beneficial and pathogenic bacteria [23–26].

Blackberry (Rubus sp.) and blueberry (Vaccinium ashei) are desired fruits because of their aromatic taste and health benefits [10, 27]. Previous studies have suggested that blackberry and blueberry anthocyanins might prevent obesity [8, 27]. However, the specific molecular mechanism underlying the antiobesity effect remains elusive. Therefore, this study investigated the potential mechanisms of blackberry anthocyanin (BLA) and blueberry anthocyanin (BBA) in diet-induced obese C57BL/6 mice.

2. Materials and Methods

2.1. Preparation of the Purified Anthocyanins

BLA and BBA were obtained from our laboratory. BLA consisted of cyanidin-3-glucoside (93.32%) and peonidin-3-glucoside (6.68%), while BBA was composed of cyanidin-3-glucoside (51.24%), cyanidin-3-rutinoside (42.31%), and peonidin-3-glucoside (6.91%).

2.2. Animals and Diets

All experimental animal procedures were approved by the Animal Care and Use Committee of Tianjin University of Science and Technology (20161012). Sixty male C57BL/6 mice (24 days of age) were obtained from the Beijing Laboratory Animal Center. The mice were allowed to acclimate for 7 days and were subsequently maintained on a 12 h light/dark cycle with free access to water and a diet. All experimental animals were divided randomly into five groups (): the LFD group—mice fed a low-fat diet (10% of calories from fat); the HFD group—mice fed a high-fat diet (45% of calories from fat); the OC group—mice fed the HFD plus orlistat at a dose of 40 mg/kg food; the BLA group—mice fed the HFD plus BLA at a dose of 200 mg/kg food; and the BBA group—mice fed the HFD plus BBA at a dose of 200 mg/kg food. The human equivalent of the anthocyanin doses was ~2 mg/kg body weight. The detailed composition of the animal diets is provided in Supplementary Table 1. All experimental mice were deprived of their diet for 12 h in week 12, anesthetized with ketamine HCl/xylazine, and killed by decapitation. Serum, liver, kidney, and adipose tissue samples were collected immediately and stored at −80°C until use.

2.3. Biochemical Analyses of Serum and Liver Samples

Serum total cholesterol (TC), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were analyzed by a Sysmex Analyzer KX-21 according to the manufacturer’s instructions. The hepatic lipid profiles were determined according to the method of Folch et al. [28]. Serum and hepatic superoxide dismutase (SOD) activity, malondialdehyde (MDA) level, and glutathione peroxidase activity (GP_X) level were characterized by the hydroxylamine method, the thiobarbituric acid method, and a cellular GP_X assay kit, respectively.

2.4. Fecal Short-Chain Fatty Acid (SCFA) Analysis

The composition and concentration of minor SCFAs, including acetic acid, propionic acid, butyric acid, isobutyric acid, isovaleric acid, and valeric acid, were characterized in mouse feces according to the method of Periago et al. [29].

2.5. Quantitative Real-Time Polymerase Chain Reaction (PCR)

Liver samples were ground in liquid nitrogen, and total RNA was extracted using TRIzol and purified in an RNeasy column. cDNA was obtained by reverse transcription from total RNA. Gene expression of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nuclear factor-κB (NF-κB) was analyzed by PCR using the One-Step SYBR PrimeScript PLUS RT-PCR kit.

2.6. Analysis of Liver Metabolites

Liver metabolite analysis was performed using Agilent 7890 gas chromatography time-of-flight mass spectrometry (GC-TOF/MS) system (Agilent Technologies, Palo Alto, CA, USA) with a capillary Agilent DB-5MS column (J&W Scientific, Folsom, CA, USA). A principal component analysis and orthogonal projections to latent structure discriminant analysis was performed with the SIMCA14.1 software package (V14.1, MKS Data Analytics Solutions, Umea, Sweden). Various hepatic metabolites, including glucose and lipid pathway intermediates, were quantified.

2.7. Statistical Analysis

Statistical analyses were performed using SPSS software version 19.0 (SPSS Inc., Chicago, IL, USA). The error of each group was calculated. Significant differences among groups were analyzed by the analysis of variance and a post hoc Duncan’s multiple range test. A value < 0.05 was considered significant.

3. Results

3.1. Effects of BLA and BBA on Body Weight Gain

C57BL/6 mice were fed a HFD supplemented with BLA or BBA at a dose of 200 mg/kg in daily food for 12 weeks to determine the antiobesity effects of BLA and BBA. At the end of the experiment, BLA, orlistat, or BBA inhibited body weight gain by 40.5%, 53.2%, or 55.4%, respectively, compared with the HFD group (Figure 1). No significant differences were observed in daily food intake (~2.8 g), the liver, or kidney throughout the experiment, whereas BLA and BBA significantly reduced the food utility and effectively increased the weight of liver tissue when expressed as a percentage of body weight (Table 1). Furthermore, the epididymal fat weight of mice in the HFD group increased when compared with mice in the LFD group, and BLA or BBA significantly attenuated this increase in weight.

3.2. Effects of BLA and BBA on Serum Lipids and Antioxidants

BLA or BBA supplementation significantly decreased serum TG, TC, LDL-C, and MDA levels and effectively increased GP_X activity when compared to the HFD-fed mice (Table 2). Moreover, BLA effectively increased HDL-C levels but did not alter leptin levels or SOD activity. However, BBA decreased for HDL-C, leptin levels, and SOD activity compared to BLA (Table 2 and Figure 2(a)).

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2

Effects of blackberry anthocyanin (BLA) and blueberry anthocyanin (BBA) consumption on serum leptin and hepatic lipids and antioxidants: (a) leptin; (b) TC; (c) TG; (d) MDA; (e) SOD; (f) GP_X. LFD: mice fed with low-fat diet; HFD: mice fed with high-fat diet; OC: mice fed with orlistat; BLA: mice fed with HFD plus BLA at doses of 200 mg/kg food; BBA: mice fed with HFD plus BBA at doses of 200 mg/kg food. Data are presented as and analyzed with ANOVA and post hoc Duncan’s multiple range tests (). The means marked with lowercase letters are significantly different relative to others.

3.3. Effects of BLA and BBA on Hepatic Lipids and Antioxidants

Hepatic TGs, TC, MDA, SOD, and GP_X were characterized at the end of the experiment. Figure 2 shows that BLA and BBA significantly reduced hepatic lipid and MDA levels and significantly elevated SOD and GPx activities, when compared with mice in the HFD group. Moreover, BBA-treated mice had significantly lower hepatic TG levels and significantly higher GP_X activity when compared to BLA-treated mice.

3.4. Effects of BLA and BBA on SCFAs

Table 3 shows that all six types of minor SCFAs decreased in the HFD group, compared with the LFD group. BBA and BLA significantly increased the concentrations of acetic acid, propionic acid, butyric acid, and valeric acid but significantly reduced isobutyric acid levels. Furthermore, the levels of acetic acid, propionic acid, and butyric acid increased significantly in BBA-treated mice compared to BLA-treated mice.

3.5. Effects of BLA and BBA on Inflammation

The expression levels of the inflammatory markers such as IL-6, TNF-α, and NF-κB in liver tissue were determined by quantitative real-time PCR (Figure 3). Administration of BBA and BLA significantly decreased gene expression levels of IL-6, TNF-α, and NF-κB when compared with those observed in HFD-fed mice. Moreover, BBA was more effective in reducing the inflammatory markers than BLA in the current experiment.

(a)

(b)

(c)

Figure 3

Effects of blackberry anthocyanin (BLA) and blueberry anthocyanin (BBA) consumption on the gene expression of inflammatory cytokine. LFD: mice fed with low-fat diet; HFD: mice fed with high-fat diet; OC: mice fed with orlistat; BLA: mice fed with HFD plus BLA at doses of 200 mg/kg food; BBA: mice fed with HFD plus BBA at doses of 200 mg/kg food. Data are presented as and analyzed with ANOVA and post hoc Duncan’s multiple range tests (). The means marked with lowercase letters are significantly different relative to others.

3.6. Effects of BLA and BBA on Hepatic Metabolites

A metabolite analysis of liver tissues was performed by GC-TOF/MS to investigate the hepatic metabolic changes after the BLA and BBA treatments. Sixty-one and sixty-three hepatic metabolites differed significantly in abundance between the BLA, BBA, and HFD groups (Supplementary Tables 2 and 3), respectively. Furthermore, 14 different metabolites were observed among the BLA, BBA, and HFD groups (Figure 4). What is more, 12 common metabolites including nine downregulated metabolites and three upregulated metabolites were found compared with the HFD group. These results indicate that consuming BLA and BBA significantly affected the hepatic lipid and glucose metabolic pathways, including glycerophospholipid metabolism, glutathione metabolism, and the insulin-signaling pathway (Figure 5).

4. Discussion

Obesity has become a leading global health problem as it causes a profound impact on morbidity and mortality [1, 30]. Recent findings suggest that fruit- and vegetable-based diets with antioxidant and anti-inflammatory activities, especially anthocyanin-rich diets, are recommended to prevent the development of metabolic diseases [23, 31–33]. In the present study, the molecular mechanism underlying the antiobesity effect of BLA and BBA was investigated in HFD-induced obesity.

R. Prior and R. L. Prior et al. reported that consuming a blueberry extract significantly reduces body weight in diet-induced obese C57BL/6 mice, while the intake of wild blueberry powder or blueberry juice does not alter body weight in obese mice [34, 35]. Wu et al. suggested that artificially planted blueberry, mulberry, and honeysuckle anthocyanins mitigate body weight gain [36–38]. In addition, Johnson et al. reported that an alcohol-free blueberry-blackberry beverage prevents the development of obesity and attenuates fasting blood glucose in C57BL/6J mice [39]. In the current study, consuming purified BLA (mainly cyanidin-3-glucoside) and BBA (mainly cyanidin-3-glucoside and cyanidin-3-rutinoside) at 200 mg/kg in the daily diet effectively inhibited body weight gain, significantly decreased serum and hepatic lipids (TC and TGs), significantly increased antioxidant activities (SOD and GP_X), and significantly attenuated inflammation. However, BBA accelerated fatty acid decomposition and attenuated liver inflammation more than BLA. These data suggest that structural differences in the anthocyanin sugar moieties may be attributed to the different antiobesity effects [35, 40].

Marques et al. reported that blackberry anthocyanin is quickly absorbed in the stomach in an intact form, while methyl-cyanidin-glucuronide and 3-methyl-cyanidin-3-glucoside are the main conjugates in plasma and urine samples [41]. Cyanidin-3-glucoside potentiates its conversion into methylated derivatives (Me-Cy-Glucr and 3-Me-Cy3glc) in overweight and obese individuals [42]. It is difficult to determine whether a particular anthocyanin is solely responsible for the antiobesity effect due to the lack of information on bioavailability [43]. Therefore, further studies are needed to identify which compounds reach the target organs.

Accumulating evidence indicates that obesity is associated with systemic oxidative stress and low-grade systemic inflammation, whereas consuming polyphenols attenuates these disease conditions [44, 45]. Our findings from the present study also demonstrate that HFD-fed obese mice exhibited pathophysiological conditions of excessive oxidative stress and inflammation accompanied by obesity. The BLA and BBA supplements significantly decreased serum and hepatic peroxidation (Table 1, Figure 2) and significantly increased hepatic SOD and GPx activities. Furthermore, administering BBA and BLA significantly downregulated IL-6, TNF-α, and NF-κB gene expression levels. However, BBA may have improved oxidative stress and inflammation more than BLA (Figures 2 and 3). These results suggest that cyanidin-3-glucoside and cyanidin-3-rutinoside may exhibit a synergistic effect on alleviating oxidative stress and inflammation.

SCFAs, particularly acetate and butyrate, present a balance between fatty acid synthesis, oxidation, and lipolysis [46, 47]. Our data suggest that consuming BBA and BLA did not alter the daily food intake of mouse but markedly decreased the weight of epididymal and retroperitoneal fat and significantly increased the fecal concentrations of acetic acid, propionic acid, and butyric acid. Moreover, the GC-TOF/MS results indicated that BLA and BBA significantly affected the hepatic lipid and glucose metabolic pathways, including glycerophospholipid metabolism, glutathione metabolism, and insulin-signaling pathways (Figure 5). These results may suggest that BLA and BBA prevent high-fat-diet-induced obesity by accelerating energy expenditure [26, 48, 49].

5. Conclusion

In conclusion, our data demonstrate that BLA and BBA inhibited body weight gain by 40.5% and 55.4%, respectively. Furthermore, BLA and BBA significantly reduced serum and hepatic lipids; significantly increased hepatic SOD and GP_X activities, as well as fecal acetate and butyrate levels; and significantly attenuated the expression of the TNF-α, IL-6, and NF-κB genes. Moreover, BLA and BBA significantly affected the hepatic lipid and glucose metabolic pathways, including glycerophospholipid metabolism, glutathione metabolism, and the insulin-signaling pathway. Therefore, BLA and BBA ameliorated diet-induced obesity by alleviating oxidative stress and inflammation and accelerating energy expenditure.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

Acknowledgments

The project programs of the Key Laboratory of Food Nutrition and Safety, Ministry of Education, China (2018004); the National Natural Science Foundation of China (31501475); and the Research Project of Tianjin Education Commission (2017ZD02) are gratefully acknowledged.

Supplementary Materials

Supplementary Table 1: composition of diets fed to mice. Supplementary Table 2: differentially expressed hepatic metabolites between BLA/HFD. Supplementary Table 3: differentially expressed hepatic metabolites between BBA/HFD. (Supplementary Materials)

References

J. Upadhyay, O. Farr, N. Perakakis, W. Ghaly, and C. Mantzoros, “Obesity as a disease,” The Medical Clinics of North America, vol. 102, no. 1, pp. 13–33, 2018.
View at: Publisher Site | Google Scholar
T. Deng, C. J. Lyon, S. Bergin, M. A. Caligiuri, and W. A. Hsueh, “Obesity, inflammation, and cancer,” Annual Review of Pathology, vol. 11, no. 1, pp. 421–449, 2016.
View at: Publisher Site | Google Scholar
K. H. Saunders, D. Umashanker, L. I. Igel, R. B. Kumar, and L. J. Aronne, “Obesity pharmacotherapy,” The Medical Clinics of North America, vol. 102, no. 1, pp. 135–148, 2018.
View at: Publisher Site | Google Scholar
G. A. Bray, G. Fruhbeck, D. H. Ryan, and J. P. Wilding, “Management of obesity,” The Lancet, vol. 387, no. 10031, pp. 1947–1956, 2016.
View at: Publisher Site | Google Scholar
R. F. Witkamp, “Current and future drug targets in weight management,” Pharmaceutical Research, vol. 28, no. 8, pp. 1792–1818, 2011.
View at: Publisher Site | Google Scholar
E. Pojer, F. Mattivi, D. Johnson, and C. S. Stockley, “The case for anthocyanin consumption to promote human health: a review,” Comprehensive Reviews in Food Science and Food Safety, vol. 12, no. 5, pp. 483–508, 2013.
View at: Publisher Site | Google Scholar
D. Li, P. Wang, Y. Luo, M. Zhao, and F. Chen, “Health benefits of anthocyanins and molecular mechanisms: update from recent decade,” Critical Reviews in Food Science and Nutrition, vol. 57, no. 8, pp. 1729–1741, 2017.
View at: Publisher Site | Google Scholar
L. Xie, H. Su, C. Sun, X. Zheng, and W. Chen, “Recent advances in understanding the anti-obesity activity of anthocyanins and their biosynthesis in microorganisms,” Trends in Food Science & Technology, vol. 72, pp. 13–24, 2018.
View at: Publisher Site | Google Scholar
A. Cassidy, K. J. Mukamal, L. Liu, M. Franz, A. H. Eliassen, and E. B. Rimm, “High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women,” Circulation, vol. 127, no. 2, pp. 188–196, 2013.
View at: Publisher Site | Google Scholar
M. Shi, H. Loftus, A. J. McAinch, and X. Q. Su, “Blueberry as a source of bioactive compounds for the treatment of obesity, type 2 diabetes and chronic inflammation,” Journal of Functional Foods, vol. 30, pp. 16–29, 2017.
View at: Publisher Site | Google Scholar
A. R. Nair, N. Mariappan, A. J. Stull, and J. Francis, “Blueberry supplementation attenuates oxidative stress within monocytes and modulates immune cell levels in adults with metabolic syndrome: a randomized, double-blind, placebo-controlled trial,” Food & Function, vol. 8, no. 11, pp. 4118–4128, 2017.
View at: Publisher Site | Google Scholar
F. J. Yan and X. D. Zheng, “Anthocyanin-rich mulberry fruit improves insulin resistance and protects hepatocytes against oxidative stress during hyperglycemia by regulating Ampk/Acc/Mtor pathway,” Journal of Functional Foods, vol. 30, pp. 270–281, 2017.
View at: Publisher Site | Google Scholar
C. H. Peng, L. K. Liu, C. M. Chuang, C. C. Chyau, C. N. Huang, and C. J. Wang, “Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis,” Journal of Agricultural and Food Chemistry, vol. 59, no. 6, pp. 2663–2671, 2011.
View at: Publisher Site | Google Scholar
J. J. Yin and T. Wu, “Anthocyanins from black wolfberry (Lycium Ruthenicum Murr.) prevent inflammation and increase fecal fatty acid in diet-induced obese rats,” RSC Advances, vol. 7, no. 75, pp. 47848–47853, 2017.
View at: Publisher Site | Google Scholar
H. Song, T. Wu, D. Xu, Q. Chu, D. Lin, and X. Zheng, “Dietary sweet cherry anthocyanins attenuates diet-induced hepatic steatosis by improving hepatic lipid metabolism in mice,” Nutrition, vol. 32, no. 7-8, pp. 827–833, 2016.
View at: Publisher Site | Google Scholar
Z. Zhou, M. G. Nair, and K. J, “Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin,” Phytomedicine, vol. 19, no. 10, pp. 878–881, 2012.
View at: Publisher Site | Google Scholar
H. Huang, X. Jiang, Z. Xiao et al., “Red cabbage microgreen lower circulating LDL, liver cholesterol and inflammatory cytokines in mice fed a high fat diet,” Journal of Agricultural and Food Chemistry, vol. 64, no. 48, pp. 9161–9171, 2016.
View at: Publisher Site | Google Scholar
S. L. Yao, Y. Xu, Y. Y. Zhang, and Y. H. Lu, “Black rice and anthocyanins induce inhibition of cholesterol absorption in vitro,” Food & Function, vol. 4, no. 11, pp. 1602–1608, 2013.
View at: Publisher Site | Google Scholar
T. Wu, X. Guo, M. Zhang, L. Yang, R. Liu, and J. Yin, “Anthocyanins in black rice, soybean and purple corn increase fecal butyric acid and prevent liver inflammation in high fat diet-induced obese mice,” Food & Function, vol. 8, no. 9, pp. 3178–3186, 2017.
View at: Publisher Site | Google Scholar
T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” The Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003.
View at: Publisher Site | Google Scholar
S. J. Shi, U. J. Bae, S. O. Ka et al., “Aqueous extracts of purple sweet potato attenuate weight gain in high fat-fed mice,” International Journal of Pharmaceutics, vol. 9, no. 1, pp. 42–49, 2013.
View at: Publisher Site | Google Scholar
Y. P. Hwang, J. H. Choi, E. H. Han et al., “Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human Hepg2 cells and obese mice,” Nutrition Research, vol. 31, no. 12, pp. 896–906, 2011.
View at: Publisher Site | Google Scholar
E. Skates, J. Overall, K. DeZego et al., “Berries containing anthocyanins with enhanced methylation profiles are more effective at ameliorating high fat diet-induced metabolic damage,” Food and Chemical Toxicology, vol. 111, pp. 445–453, 2018.
View at: Publisher Site | Google Scholar
X. Zhang, Y. Zhu, F. Song et al., “Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: a randomized controlled trial,” Nutrition & Metabolism, vol. 13, no. 1, p. 86, 2016.
View at: Publisher Site | Google Scholar
G. Jamar, D. Estadella, and L. P. Pisani, “Contribution of anthocyanin-rich foods in obesity control through gut microbiota interactions,” BioFactors, vol. 43, no. 4, pp. 507–516, 2017.
View at: Publisher Site | Google Scholar
Y. Ravussin, R. Gutman, C. A. LeDuc, and R. L. Leibel, “Estimating energy expenditure in mice using an energy balance technique,” International Journal of Obesity, vol. 37, no. 3, pp. 399–403, 2013.
View at: Publisher Site | Google Scholar
B. Kim, S. G. Lee, Y. K. Park et al., “Blueberry, blackberry, and blackcurrant differentially affect plasma lipids and pro-inflammatory markers in diet-induced obesity mice,” Nutrition Research and Practice, vol. 10, no. 5, pp. 494–500, 2016.
View at: Publisher Site | Google Scholar
L. Folch, M. Lees, and G. H. Sloane Stanley, “A simple method for the isolation and purification of the total lipids from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957.
View at: Google Scholar
M. J. Periago, G. Martin-Pozuelo, R. Gonzalez-Barrio et al., “Effect of tomato juice consumption on the plasmatic lipid profile, hepatic Hmgcr activity, and fecal short chain fatty acid content of rats,” Food & Function, vol. 7, no. 10, pp. 4460–4467, 2016.
View at: Publisher Site | Google Scholar
J. Pearson-Stuttard, B. Zhou, V. Kontis, J. Bentham, M. J. Gunter, and M. Ezzati, “Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment,” The Lancet Diabetes and Endocrinology, vol. 6, no. 2, pp. 95–104, 2018.
View at: Publisher Site | Google Scholar
G. Noratto, H. S. Martino, S. Simbo, D. Byrne, and S. U. Mertens-Talcott, “Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats,” The Journal of Nutritional Biochemistry, vol. 26, no. 6, pp. 633–641, 2015.
View at: Publisher Site | Google Scholar
G. D. Noratto, B. P. Chew, and L. M. Atienza, “Red raspberry (Rubus idaeus L.) intake decreases oxidative stress in obese diabetic (Db/Db) mice,” Food Chemistry, vol. 227, pp. 305–314, 2017.
View at: Publisher Site | Google Scholar
W. Huang, Z. Yan, D. Li, Y. Ma, J. Zhou, and Z. Sui, “Antioxidant and anti-inflammatory effects of blueberry anthocyanins on high glucose-induced human retinal capillary endothelial cells,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 1862462, 10 pages, 2018.
View at: Publisher Site | Google Scholar
R. Prior, “Anthocyanins and weight loss,” CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, vol. 5, no. 29, pp. 1–9, 2010.
View at: Publisher Site | Google Scholar
R. L. Prior, S. Wilkes, T. Rogers et al., “Dietary black raspberry anthocyanins do not alter development of obesity in mice fed an obesogenic high-fat diet,” Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 3977–3983, 2010.
View at: Publisher Site | Google Scholar
T. Wu, J. Yin, G. Zhang, H. Long, and X. Zheng, “Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet-induced obese mice,” Molecular Nutrition & Food Research, vol. 60, no. 3, pp. 687–694, 2016.
View at: Publisher Site | Google Scholar
T. Wu, Z. Yu, Q. Tang et al., “Honeysuckle anthocyanin supplementation prevents diet-induced obesity in C57bl/6 mice,” Food & Function, vol. 4, no. 11, pp. 1654–1661, 2013.
View at: Publisher Site | Google Scholar
T. Wu, Z. Jiang, J. Yin, H. Long, and X. Zheng, “Anti-obesity effects of artificial planting blueberry (Vaccinium ashei) anthocyanin in high-fat diet-treated mice,” International Journal of Food Sciences and Nutrition, vol. 67, no. 3, pp. 257–264, 2016.
View at: Publisher Site | Google Scholar
M. H. Johnson, M. Wallig, D. A. Luna Vital, and E. G. de Mejia, “Alcohol-free fermented blueberry-blackberry beverage phenolic extract attenuates diet-induced obesity and blood glucose in C57BL/6J mice,” The Journal of Nutritional Biochemistry, vol. 31, pp. 45–59, 2016.
View at: Publisher Site | Google Scholar
A. Castaneda-Ovando, M. D. Pacheco-Hernandez, M. E. Paez-Hernandez, J. A. Rodriguez, and C. A. Galan-Vidal, “Chemical studies of anthocyanins: a review,” Food Chemistry, vol. 113, no. 4, pp. 859–871, 2009.
View at: Publisher Site | Google Scholar
C. Marques, I. Fernandes, S. Norberto et al., “Pharmacokinetics of blackberry anthocyanins consumed with or without ethanol: a randomized and crossover trial,” Molecular Nutrition & Food Research, vol. 60, no. 11, pp. 2319–2330, 2016.
View at: Publisher Site | Google Scholar
R. M. de Ferrars, C. Czank, Q. Zhang et al., “The pharmacokinetics of anthocyanins and their metabolites in humans,” British Journal of Pharmacology, vol. 171, no. 13, pp. 3268–3282, 2014.
View at: Publisher Site | Google Scholar
W. Kalt, J. E. McDonald, M. R. Vinqvist-Tymchuk, Y. Liu, and S. A. E. Fillmore, “Human anthocyanin bioavailability: effect of intake duration and dosing,” Food & Function, vol. 8, no. 12, pp. 4563–4569, 2017.
View at: Publisher Site | Google Scholar
Y. T. Tung, H. L. Chen, H. S. Wu, M. H. Ho, K. Y. Chong, and C. M. Chen, “Kefir peptides prevent hyperlipidemia and obesity in high-fat-diet-induced obese rats via lipid metabolism modulation,” Molecular Nutrition & Food Research, vol. 62, no. 3, 2018.
View at: Publisher Site | Google Scholar
F. T. Rosa, M. A. Zulet, J. S. Marchini, and J. A. Martinez, “Bioactive compounds with effects on inflammation markers in humans,” International Journal of Food Sciences and Nutrition, vol. 63, no. 6, pp. 749–765, 2012.
View at: Publisher Site | Google Scholar
J. Liobikas, K. Skemiene, S. Trumbeckaite, and V. Borutaite, “Anthocyanins in cardioprotection: a path through mitochondria,” Pharmacological Research, vol. 113, Part B, pp. 808–815, 2016.
View at: Publisher Site | Google Scholar
J. Tan, C. McKenzie, P. J. Vuillermin et al., “Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways,” Cell Reports, vol. 15, no. 12, pp. 2809–2824, 2016.
View at: Publisher Site | Google Scholar
Y. You, X. Han, J. Guo et al., “Cyanidin-3-glucoside attenuates high-fat and high-fructose diet-induced obesity by promoting the thermogenic capacity of brown adipose tissue,” Journal of Functional Foods, vol. 41, pp. 62–71, 2018.
View at: Publisher Site | Google Scholar
Y. You, X. Yuan, X. Liu et al., “Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function,” Molecular Nutrition & Food Research, vol. 61, no. 11, article 1700261, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2018 Tao Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

3621

Downloads

1699

Citations